AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12916-022-02342-z
PubMed Identifier: 35346184
Publication URI: http://europepmc.org/abstract/MED/35346184
Type: Journal Article/Review
Volume: 20
Parent Publication: BMC medicine
Issue: 1
ISSN: 1741-7015